About Subira Pharmaceuticals Private Limited
Data last updated: 17 February 2026
Subira Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 08 October 2013, the company has been in operation for over 13 years.
Registered with ROC Mumbai under CIN U24233MH2013PTC328984.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishal Khanna and Kavita Khanna.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2024, the company reported a revenue of ₹45.51 Cr, a growth of 32% compared to the previous year.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹2.21 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website subirapharma.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressA – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24233HR2013PTC050627. The current CIN is U24233MH2013PTC328984, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233MH2013PTC328984 | Current |
| U24233HR2013PTC050627 | Previous |
Business Activity of Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Subira Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals Private Limited is audited by K M GARG & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K M GARG & CO. | Locked | Locked | Locked |
Complete auditor history for Subira Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Khanna | Director | 08 Oct 2013 | 12 Years 9 Months | Current |
| Kavita Khanna | Director | 08 Oct 2013 | 12 Years 9 Months | Current |
Financials of Subira Pharmaceuticals Private Limited FY 2025 filings available
Subira Pharmaceuticals Private Limited reported revenue of ₹45.51 Cr (up 32.00% YoY) for FY 2024.
Ten-year financial statements for Subira Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Subira Pharmaceuticals Private Limited
Shareholding and ownership data for Subira Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Subira Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2025 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 04 May 2022 | Hdfc Bank Limited | ₹25 Lakh | Satisfied |
| 01 Dec 2020 | Others | ₹1.96 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Subira Pharmaceuticals Private Limited
View historical data on people associated with Subira Pharmaceuticals Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Subira Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Subira Pharmaceuticals Private Limited
GST registrations and filing compliance for Subira Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Subira Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Subira Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Subira Pharmaceuticals Private Limited
MSME payment history for Subira Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Subira Pharmaceuticals Private Limited
Corporate group structure for Subira Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Subira Pharmaceuticals Private Limited
MCA filings and documents for Subira Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Subira Pharmaceuticals Private Limited
Frequently Asked Questions about Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 08 October 2013 (13+ years old) and is registered under CIN U24233MH2013PTC328984.
Subira Pharmaceuticals Private Limited reported revenue of ₹45.51 Cr for FY 2024 (up 32.00% YoY).
The current directors of Subira Pharmaceuticals Private Limited are:
- Vishal Khanna - Director
- Kavita Khanna - Director
The primary industry of Subira Pharmaceuticals Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Subira Pharmaceuticals Private Limited can be reached at the registered office: A – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053, or through the website subirapharma.in.
The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.